Birmingham, West Midlands -- (SBWIRE) -- 01/13/2014 -- Value Penny Stocks issues special report on Capstone Turbine Corporation (NASDAQ:CPST), American Airlines Group Inc. (NASDAQ:AAL), PulteGroup, Inc. (NYSE:PHM), Immunomedics, Inc. (NASDAQ:IMMU).
Capstone Turbine Corporation (NASDAQ:CPST) opened its last trade at the price of $1.60. Its closing price was $1.51 after losing -3.82% for the day. The company traded with the total volume of 9,485,021 shares, while its average trading volume remained 3.77 million shares. The beta of this stock stands at 1.96. Capstone Turbine Corporation engages in developing, manufacturing, marketing, and servicing microturbine technology solutions for use in stationary distributed power generation applications worldwide.
Has CPST Found The Bottom and Ready To Move Up? Find Out Here
American Airlines Group Inc. (NASDAQ:AAL) percentage change plunged 0.24% to close at $29.35 with the total traded volume of 12,824,160 shares, along with average volume of 11,990,600 shares. The 52 week range of the stock remained $12.70 - $29.83. American Airlines Group Inc., through its subsidiaries, operates in the airline industry. It operates an average of approximately 6,700 flights per day to approximately 339 destinations in 54 countries from its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C.
Has AAL Found The Bottom And Ready To Gain Momentum? Find Out Here
PulteGroup, Inc. (NYSE:PHM) traded on volume of 11,385,839 shares in the last session against average volume of 6.63 million shares. The company started its trading session with the price of $19.73 and closed at $20.16 by scoring +1.87%. PulteGroup, Inc., through its subsidiaries, engages in homebuilding and financial services businesses primarily in the United States. The company’s Homebuilding segment is involved in the acquisition and development of land primarily for residential purposes within the United States; and the construction of housing on such lands.
Will PHM Continue To Move Higher? Find Out Here
Immunomedics, Inc. (NASDAQ:IMMU) started its last trading session with the price of $5.94 and closed at $6.10 by scoring +17.79%. The stock traded with total volume of 8,748,267 shares, while the average trading volume remained 1.23 million shares. The beta value of this stock stands at 1.91. Day range for the stock was $5.55 - $6.11. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases. Its products include epratuzumab, which is in two Phase III clinical trials for the treatment of lupus.
Why Should Investors Buy IMMU After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)